
Sign up to save your podcasts
Or
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XJK865. CME credit will be available until February 25, 2026.
Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies
Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.
Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Disclosure information is available at the beginning of the video presentation.
4.1
2525 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XJK865. CME credit will be available until February 25, 2026.
Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies
Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.
Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Disclosure information is available at the beginning of the video presentation.
43,660 Listeners
137 Listeners
319 Listeners
701 Listeners
500 Listeners
28 Listeners
10 Listeners
1,383 Listeners
5 Listeners
10 Listeners
4 Listeners
2 Listeners
4 Listeners
2 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
2 Listeners
12 Listeners
2 Listeners
4 Listeners
3 Listeners
5 Listeners
289 Listeners
259 Listeners
3,339 Listeners
1,149 Listeners
190 Listeners
88 Listeners
514 Listeners
369 Listeners
432 Listeners